OPXT, LXRX, FRM, FOLD, ACIW, PZG Expected to Trade Up After Bullish Patterns Develop
June 14, 2011 / M2 PRESSWIRE / BUYINS.NET / http://www.squeezetrigger.com is monitoring top technical trading patterns and these stocks are the most likely to trade Up in the coming weeks. OPNEXT INC (NASDAQ:OPXT), LEXICON PHARMACEUTICALS INC (NASDAQ:LXRX), FURMANITE CORP (NYSE:FRM), AMICUS THERAPEUTICS INC (NASDAQ:FOLD), ACI WORLDWIDE INC (NASDAQ:ACIW), PARAMOUNT GOLD AND SILVER (AMEX:PZG) are all expected to go Up as Bullish signals have been generated by top technical trading patterns. We monitor these patterns: Support Break, Support Reversal, Breakaway Gap, Measured Gap, Exhaustion Gap, Resistance Break, Resistance Reversal, Saucer Reversal, Volume Climax, Volume Trend, Fibonacci Reversal, Consolidation Breaks, Trend Line Break,Trend Line Reversal, Candles, Golden Crosses, Death Crosses and more. The chart below displays the stocks expected to go Up along with pattern, strategy and strength ratings.
Symbol Company Strategy Pattern Name Strength OPXT OPNEXT INC Trending (Stocks) DO Rounded Top 3 LXRX LEXICON PHARMACEUTICALS INC Reversal (Stocks) DWC Trend Line Reversal(5+) 1 FRM FURMANITE CORP Reversal (Stocks) DWC Trend Line Reversal(5+) 1 FOLD AMICUS THERAPEUTICS INC Breakout (Stocks) DO Trend Line Break(3) 2 ACIW ACI WORLDWIDE INC Reversal (Stocks) DWC Trend Line Break(5+) 2 PZG PARAMOUNT GOLD AND SILVER Trending (Stocks) DO Wedge, Falling Continuation 1Chart Pattern Recognition is based on a 20-year patterns database. This database is used to determine pattern strength for patterns as they appear. There is no optimization and the pattern signals never change. For each pattern variation, we record accuracy and profitability statistics in a patterns database. From this information, we are able to define strength ratings from 1 to 5. The '1' rating shows ALL patterns while a '5' rating shows the best patterns according to profitability. Each pattern has its own strength rating factors. The result is an automatic ranking system that allows us to only show the BEST patterns. You can see that, at Strength 5, virtually all the patterns are profitable. The pattern strength rating system separates the most profitable patterns. The specific technology used to make these predictions is available for a low monthly fee at: http://www.squeezetrigger.com/services/sw/ot.php
OPNEXT INC (NASDAQ:OPXT) - Opnext, Inc., together with its subsidiaries, designs and manufactures optical subsystems, modules, and components for communication uses primarily in North America, Europe, Japan, and Asia Pacific. The companys optical communications components consist of transmitters and receivers that include a hermetically packaged compound semiconductor laser or photo detectors, which utilize internally fabricated lasers or photo detectors built from indium phosphide or gallium arsenide compound semiconductor materials systems. Its optical transceiver modules convert signals between electrical and optical for transmitting and receiving data over fiber optic networks, and provide the physical communications interface for data communications and telecommunications systems. The optical transceiver modules are used for client-side interfaces consisting of short distance dedicated fiber cables, as well as line-side interfaces, which include long distance transmission with shared fiber cable and amplification media. Opnexts subsystems provide 40Gbps or 100Gbps long-distance optical communications. The companys customers include companies that design and manufacture laser-based products, including medical and scientific systems, industrial bar code scanners, professional grade construction and surveying tools, gun sights and other security equipment, display and projection systems for mini-projectors and other projection applications, sensors for robotics and industrial automation, and printing engines for high-speed laser printers and plain paper copiers. Opnext, Inc. founded in 2000 and is headquartered in Fremont, California.
LEXICON PHARMACEUTICALS INC (NASDAQ:LXRX) - Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of human diseases in the areas of cardiology, gastroenterology, immunology, metabolism, and ophthalmology. The companys drug candidates include LX1031, which has completed Phase II clinical trials for the treatment of irritable bowel syndrome and other gastrointestinal disorders; LX4211 that has completed Phase II clinical trials to treat type 2 diabetes; LX2931, which is in Phase II clinical trials for the treatment of rheumatoid arthritis and other autoimmune diseases; and LX1032 that has completed Phase II clinical trials to treat the symptoms associated with carcinoid syndrome. It also has a preclinical development drug candidate, LX7101, for the treatment of glaucoma. The company has drug discovery alliances with Bristol-Myers Squibb Company; Genentech, Inc.; N.V. Organon; and Takeda Pharmaceutical Company Limited. It also has drug development financing collaboration with Symphony Icon; and an alliance with Nuevolution A/S, which provides access to Nuevolutions Chemetics platform chemistry technology. Lexicon Pharmaceuticals, Inc. was formerly known as Lexicon Genetics Inc. and changed its name on April 26, 2007. The company was founded in 1995 and is headquartered in The Woodlands, Texas.
FURMANITE CORP (NYSE:FRM) - Furmanite Corporation, through its subsidiaries, provides technical services in Europe, North America, Latin America, the Middle East, Africa, and the Asia Pacific. It provides on-line repairs of leaks in valves, pipes, and other components of piping systems and related equipment used in flow-process industries; and on-site machining, bolting, valve repair, heat treating, and repair on such systems and equipment. The company also offers hot topping, line stopping, composite repair, and valve testing services and other engineering services, as well as provides diagnostic services for valves through its patented Trevitest system. In addition, it provides concrete repair, valve and other product manufacturing, and heat exchanger design and repair services. Additionally, the company offers consulting and other support services to federal government agencies. It serves petroleum refineries, chemical plants, mining operations, offshore energy production platforms, steel mills, nuclear power stations, conventional power stations, pulp and paper mills, food and beverage processing plants, and other flow-process facilities. The company was formerly known as Xanser Corporation and changed its name to Furmanite Corporation in May 2007. Furmanite Corporation was founded in 1952 and is headquartered in Richardson, Texas.
AMICUS THERAPEUTICS INC (NASDAQ:FOLD) - Amicus Therapeutics Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of orally-administered, small molecule drugs for the treatment of various human genetic diseases. Its drugs are known as pharmacological chaperones, which selectively bind to the target protein, increase the stability of the protein, help it fold into the three-dimensional shape, and allow proper trafficking of the protein, thereby increasing protein activity, enhance cellular function, and reduce cell stress. The company primarily focuses on lysosomal storage disorders and diseases of neurodegeneration. Its lead product candidate includes Amigal, which is in Phase III development for the treatment of Fabry disease. The company also develops AT2220, which is in Phase I testing for the treatment of Pompe disease. In addition, it develops Plicera for the treatment of Gaucher disease. The company was founded in 2002 and is based in Cranbury, New Jersey.
ACI WORLDWIDE INC (NASDAQ:ACIW) - ACI Worldwide, Inc. develops, markets, installs, and supports software products and services to facilitate electronic payments worldwide. It offers initiate products, including ACI Enterprise Banker that provides customers with electronic payment initiation capability, information reporting, and other payment related services; and ACI Global Banker, which offers access to corporate cash management, trade finance, FX services, reporting, and data exchange. The company also provides manage products comprising retail payment engines that are designed to route electronic payment transactions from transaction generators to the acquiring institutions for the authorization of payment; back office services, which are card issuing and merchant management solutions; and wholesale payments solutions, such as high value payments processing, bulk payments processing, global messaging, and continuous link settlement processing. In addition, ACI Worldwide offers secure products consisting of ACI Proactive Risk Manager, a neural network-based fraud detection system; ACI Automated Case Management System, a framework that defines processes for researching and resolving cases, including investigation resources, timeframes, escalation paths, and alerts; and ACI Automated Case Management System for Anti-Money Laundering to automate the escalation and notification processing of potential non-compliance exposure. Further, its operate products offer specific technology extensions to augment the business services provided in the initiate, manage, and secure solutions. It has strategic alliances with Hewlett-Packard Company, IBM Corporation, and Oracle Corporation. The company sells its products through distributors and sales agents to retailers and electronic payment processors. The company was formerly known as Transaction Systems Architects, Inc. and changed its name to ACI Worldwide, Inc. in July 2007. ACI Worldwide, Inc. was founded in 1993 and is headquartered in New York, New York.
PARAMOUNT GOLD AND SILVER (AMEX:PZG) - Paramount Gold and Silver Corp. engages in the acquisition, exploration, and development of gold, silver, and precious metal properties primarily in Mexico, as well as in British Columbia, Canada. It primarily explores and develops the San Miguel Project located in the State of Chihuahua, Mexico. The company was formerly known as Paramount Gold Mining Corp. and changed its name to Paramount Gold and Silver Corp. in August 2007. Paramount Gold and Silver Corp. was founded in 2005 and is based in Ottawa, Canada.
About BUYINS.NET
BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS
Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"
RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO
INVESTMENTS & TRADING
SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.
Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.
Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.
Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.
Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.
GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.
DISCLAIMER:
BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.
Contact:
BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net